麻豆传媒

Meta-analysis suggested lower stroke risk, but more definitive trial is not expected until 2032

Continued OAC failed to meet noninferiority in POPular PAUSE TAVI

Trial paints a fuller picture of risk-benefit in complex patient population

RESHAPE-HF2 has provocative implications for a wider pool of TEER candidates

First randomized trial debunks common practice of tight control

Either choice is "acceptable" based on randomized study

Sex should factor into tailoring of postoperative care, research suggests

PD-L1 checkpoint inhibitor approved for use in NSCLC before and after surgery

ACE-PROTAVI trial tested upfront vs selective use of heparin reversal agent

Predictors of POAF burden, late-occurring POAF identified in prospective study

Committee unanimously backs mandating trial design to distinguish effects of therapy phases

Financial rewards increase participation in guideline-recommended programs

"Failure to rescue" may help with quality improvement in interventional cardiology

But definitive proof on timing of procedures still lacking